KZA 0.00% 8.0¢ kazia therapeutics limited

This free article provides a good summary of further disease...

  1. 114 Posts.
    lightbulb Created with Sketch. 125
    This free article provides a good summary of further disease targets for a brain penetrant PI3K/mTOR inhibitor like paxalisib (see last point of tinhat‘s post above):

    https://dx.doi.org/10.3390%2Fijms20225792
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.